Tarceva (erlotinib)
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 55 (Table of Contents)
Published: 5 Jan-2005
DOI: 10.3833/pdr.v2005.i55.743 ISSN: 1756-7874
Section: Deal Trackers
Fulltext:
Abstract
The small molecule drug Tarceva™ provides a further option for patients who have already undergone aggressive chemotherapy for locally advanced or metastatic non-small-cell lung cancer (NSCLC), which accounts for almost 80% of all lung cancers...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS